Practice Management News

Two phase 3 trials found that lebrikizumab was effective against moderate-to-severe atopic dermatitis in adolescents and adults, researchers reported in The New England Journal of Medicine.

You are asked to see a 14-year-old girl for recurrent, draining sores in the bilateral groin areas for over a year. She did not want to tell her parents, fearing what they might think, even though she was not sexually active.

As a part of a comprehensive health care compliance program, every medical practice should conduct regular exclusion screening.

SEATTLE — Because people with HIV who are being successfully treated with ART have a close to normal life expectancy, most deaths among those with HIV are now caused by unrelated comorbidities, a study found.

NEW ORLEANS — Gladskin and Level Ex have partnered to create a medical video game designed to teach dermatologists how Gladskin’s eczema cream works to restore the skin’s microbiome.

Private equity has had a long involvement with and continues to stay active in the business of health care.

NEW ORLEANS — In this Healio video exclusive from the American Academy of Dermatology Annual Meeting, Art Papier, MD, founder and CEO of VisualDx, describes the company’s goals for use in a dermatology setting.

NEW ORLEANS — Johnson & Johnson presented data in multiple areas at the American Academy of Dermatology Annual Meeting.

NEW ORLEANS — Clinicians should be mindful of pigmentary concerns and colorism in their patients with skin of color and recognize the motivations behind skin lightening desires, according to a study presented here.

L’Oréal has gifted a $100,000 grant to the Skin of Color Society for the advancement of research and education in dermatological diseases among patients with skin of color, according to a company press release.